Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Chantix / Champix [legacy through FY22] by Quarter
Chantix / Champix (varenicline) [legacy through FY22] ($M) ($M)
Pfizer Chantix / Champix [legacy through FY22]: $0M in Q4 2022, down 100.0% from a year earlier. No newer figure appears in the documents we track.
Where the Q4 2022 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: Form 10-K (filed 2023-02-23) ↗
Reported in Form 10-K Segment Note.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Chantix / Champix (varenicline) [legacy through FY22] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2022 | Dec 31, 2022 | 0 | -100.0% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2022 | Oct 2, 2022 | 4 | -42.9% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jul 3, 2022 | 1 | -99.5% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2022 | Apr 3, 2022 | 2 | -99.1% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2021 | Dec 31, 2021 | -11 | -105.8% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2021 | Oct 3, 2021 | 7 | -96.9% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2021 | Jul 4, 2021 | 184 | -21.7% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2021 | Apr 4, 2021 | 217 | -19.6% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2020 | Dec 31, 2020 | 191 | -32.3% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2020 | Sep 27, 2020 | 223 | -19.2% | Form 10-Q (filed 2021-11-12) ↗ |
| Q2 2020 | Jun 28, 2020 | 235 | -14.9% | Form 10-Q (filed 2021-08-12) ↗ |
| Q1 2020 | Mar 29, 2020 | 270 | -1.1% | Form 10-Q (filed 2021-05-13) ↗ |
| Q4 2019 | Dec 31, 2019 | 282 | -4.7% | Form 10-K (filed 2022-02-24) ↗ |
| Q3 2019 | Sep 29, 2019 | 276 | +5.7% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 276 | -0.4% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 273 | +8.8% | Form 10-Q (filed 2020-05-07) ↗ |
| Q4 2018 | Dec 31, 2018 | 296 | – | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2018 | Sep 30, 2018 | 261 | – | Form 10-Q (filed 2019-11-07) ↗ |
| Q2 2018 | Jul 1, 2018 | 277 | – | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2018 | Apr 1, 2018 | 251 | – | Form 10-Q (filed 2019-05-09) ↗ |
Cite this data
StockData. (2026). Pfizer Chantix / Champix [legacy through FY22] ($M), quarterly Q1 2018–Q4 2022 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/chantix-leg
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.